# Stéphane Barakat

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/stephane-barakat/

## Facts

| Field | Value |
| --- | --- |
| Citations | 512 |
| Field | Acute Myeloid Leukemia Research |
| h-index | 11 |
| i10-index | 11 |
| Last Known Institution | ABB (Canada) |
| OpenAlex ID | https://openalex.org/A5110355979 |
| Works | 51 |

## Researcher papers

- [Scl regulates the quiescence and the long-term competence of hematopoietic stem cells](https://scholariq.org/papers/scl-regulates-the-quiescence-and-the-long-term-competence-of-hematopoietic-stem/)
- [Modulation of p‐glycoprotein function by caveolin‐1 phosphorylation](https://scholariq.org/papers/modulation-of-p-glycoprotein-function-by-caveolin-1-phosphorylation/)
- [Control of P-Glycoprotein Activity by Membrane Cholesterol Amounts and Their Relation to Multidrug Resistance in Human CEM Leukemia Cells](https://scholariq.org/papers/control-of-p-glycoprotein-activity-by-membrane-cholesterol-amounts-and-their/)
- [Modulation of P‐glycoprotein function by sphingosine kinase‐1 in brain endothelial cells](https://scholariq.org/papers/modulation-of-p-glycoprotein-function-by-sphingosine-kinase-1-in-brain/)
- [Regulation of brain endothelial cells migration and angiogenesis by P-glycoprotein/caveolin-1 interaction](https://scholariq.org/papers/regulation-of-brain-endothelial-cells-migration-and-angiogenesis-by-p/)
- [Multidrug-resistant cancer cells contain two populations of P-glycoprotein with differently stimulated P-gp ATPase activities: evidence from atomic force microscopy and biochemical analysis](https://scholariq.org/papers/multidrug-resistant-cancer-cells-contain-two-populations-of-p-glycoprotein-with/)
- [<p>Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug Review</p>](https://scholariq.org/papers/and-lt-p-and-gt-can-standard-health-technology-assessment-approaches-help-guide/)
- [Early access for innovative oncology medicines: a different story in each nation](https://scholariq.org/papers/early-access-for-innovative-oncology-medicines-a-different-story-in-each-nation/)
- [Quality of Life in Wilson’s Disease: A Systematic Literature Review](https://scholariq.org/papers/quality-of-life-in-wilson-s-disease-a-systematic-literature-review/)
- [A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada](https://scholariq.org/papers/a-probabilistic-cost-effectiveness-analysis-of-venetoclax-and-obinutuzumab-as-a/)

## Researcher topics

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Drug Transport and Resistance Mechanisms](https://scholariq.org/topics/drug-transport-and-resistance-mechanisms/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Ocular Oncology and Treatments](https://scholariq.org/topics/ocular-oncology-and-treatments/)
- [Retinoids in leukemia and cellular processes](https://scholariq.org/topics/retinoids-in-leukemia-and-cellular-processes/)

## Researcher university

- [ABB (Canada)](https://scholariq.org/institutions/abb-canada/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.